首页
400-620-6333
药靶抗体
-
-
Nadunolimab (anti-IL-1 RAcP)关联靶标: IL1RAP种属反应性: Human,Mouse 亚型: Human IgG1偶联: UnconjugatedCAS号 : 2171061-85-9
-
Emicizumab (anti-Factor IX)种属反应性: Cynomolgus monkey,Human 亚型: Human IgG4SP偶联: UnconjugatedCAS号 : 1610943-06-0
-
Sacituzumab (anti-TROP2)关联靶标: TACSTD2种属反应性: Human 亚型: Human IgG1偶联: UnconjugatedCAS号 : 1796566-95-4
-
Denosumab (anti-TNFSF11)关联靶标: TNFSF11种属反应性: Cynomolgus monkey,Human 亚型: Human IgG1偶联: UnconjugatedCAS号 : 615258-40-7
-
Pamrevlumab (anti-CTGF)关联靶标: CTGF种属反应性: Human,Mouse,Rabbit,Rat 亚型: Human IgG1偶联: UnconjugatedCAS号 : 946415-13-0
-
Vibostolimab (anti-TIGIT)关联靶标: TIGIT种属反应性: Cynomolgus monkey,Human,Rhesus Macaque 亚型: Human IgG1偶联: UnconjugatedCAS号 : 2231305-30-7
-
Panitumumab (anti-EGFR)关联靶标: EGFR种属反应性: Human 亚型: Human IgG2SA偶联: UnconjugatedCAS号 : 339177-26-3 Compound CID : 168009961IUPAC Name: 4-[4-amino-1-[1-[4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(4-ethylpyridin-2-yl)benzamide;4-[4-amino-1-[1-[4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxy-N-(4-methylpyridin-2-yl)benzamide;4-[4-amino-1-[1-[4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(5-methyl-1,3-thiazol-2-yl)benzamideSMILES: CCC1=CC(=NC=C1)NC(=O)C2=CC=C(C=C2)C3=NN(C4=NC=NC(=C34)N)C5CCN(C5)C(=O)C=CCN(C)C6CC6.CC1=CC(=NC=C1)NC(=O)C2=C(C=C(C=C2)C3=NN(C4=NC=NC(=C34)N)C5CCN(C5)C(=O)C=CCN(C)C6CC6)OC.CC1=CN=C(S1)NC(=O)C2=CC=C(C=C2)C3=NN(C4=NC=NC(=C34)N)C5CCN(C5)C(=O)C=CCN(C)C6CC6InChIKey: ZJEDKXXULJUKFQ-UHFFFAOYSA-NInChI: InChI=1S/C31H35N9O3.C31H35N9O2.C28H31N9O2S/c1-19-10-12-33-25(15-19)36-31(42)23-9-6-20(16-24(23)43-3)28-27-29(32)34-18-35-30(27)40(37-28)22-11-14-39(17-22)26(41)5-4-13-38(2)21-7-8-21;1-3-20-12-14-33-25(17-20)36-31(42)22-8-6-21(7-9-22)28-27-29(32)34-19-35-30(27)40(37-28)24-13-16-39(18-24)26(41)5-4-15-38(2)23-10-11-23;1-17-14-30-28(40-17)33-27(39)19-7-5-18(6-8-19)24-23-25(29)31-16-32-26(23)37(34-24)21-11-13-36(15-21)22(38)4-3-12-35(2)20-9-10-20/h4-6,9-10,12,15-16,18,21-22H,7-8,11,13-14,17H2,1-3H3,(H2,32,34,35)(H,33,36,42);4-9,12,14,17,19,23-24H,3,10-11,13,15-16,18H2,1-2H3,(H2,32,34,35)(H,33,36,42);3-8,14,16,20-21H,9-13,15H2,1-2H3,(H2,29,31,32)(H,30,33,39)
-
Canakinumab (Anti-IL-1b)关联靶标: IL1B种属反应性: Human,Mouse 亚型: Human IgG1偶联: UnconjugatedCAS号 : 914613-48-2
-
Bemarituzumab (anti-FGFR2)种属反应性: Cynomolgus monkey,Human,Mouse 亚型: Human IgG1偶联: UnconjugatedCAS号 : 1952272-74-0
-
-
Erenumab (anti-CALCRL)种属反应性: Cynomolgus monkey,Human 亚型: Human IgG2SA偶联: UnconjugatedCAS号 : 1582205-90-0
